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Freshly isolated rat hepatocytes ynthesize and secrete hepaiic lipase (HL). Comparison of secreted HL with 
intracellular HL indicates a secretion-linked increase in the specific enzyme activity. (a) Immunotitration with 
polyclonal anti-HL showed a 3-5-fold lower specific enzyme activity of intracellular HL than of secreted HL. This 
was confirmed by ELISA using a mixture of monoclonal anti.HL's. (b) After isolation on Sepharose-heparin, a 
similar difference in specific enzyme activity was observed, whereas the apparent Km for glyceroltrioleate was not 
different. (c) IlL activity secreted in the absence of protein de novo synthesis was 5-fold higher than was accounted 
for by the fall in intracellular activity, whereas HL protein lost from the cells was near-completely recovered in the 
extraeellular medium. (d) The presence of inactive HL pr~tein was demonstrated in ceils treated with castanosper- 
mine, which inhibits secretion of newly synthesized HL by interl~ring with maturation at an early stage of N-linked 
oligosaccharide processing. Upon removal of castanospermine, secretion of HL activity recovered, even when protein 
de novo synthesis was inhibited, strongly suggesting that part of the inactive HL was mobilized and became 
activated, This secretion-coupled increase in HL activity in the absence of protein synthesis uggests the existence of 
inactive precursor within rat hepatocytes. The catalytic activity of HL becomes apparent upon maturation of the 
protein after oligosaccharide processing by the rough endoplasmic reticulum glucosidases. 
Introduction 
Hepatic lipase (HL) is a lipotytic enzyme that plays a 
central role Jn lipoprotein metabolism. It is present in 
the liver of most vertebrates where it is localized at the 
extracellular surface of endothelial cells lining the blood 
sinusoids and from where it can be released by heparin 
infusion [1]. HL is synthesized and constitutively se- 
creted by liver parenchymal cells. Post-heparin HL 
activity is lower in patients with angiographic evidence 
for coronary atherosclerosis than in patients without 
such signs [2]. In addition, HL activity correlated with 
the development of coronary atherosclerosis in patients 
Abbreviations: BSA, bovine serum albumin: CHAPS, 3-[(3-cholami- 
dopropyl)dimethylammonio]-l-propane-sulfonate; HL, hepatic li- 
pase; lgG, immunoglobulin G: LPL, lipoprotein lipase; PAGE, poly- 
acrylamide gelelectrophoresis; PBS, Dulbecco's phosphate-buffered 
saline: PMSF, phenylmethylsulfonyl fluoride: SDS, sodium dodecyl 
sulfate, 
Correspondence: A.J.M. Verhoeven, Dept. Biochemistry I. Erasmus 
University, POB 1738, 3000 DR Rotterdam, The Netherlands. 
on a lipid-lowering diet [3]. HL is thought to reduce 
atherosclerotic risk, either by reducing the number of 
atherogenic particles in circulation, such as IDL [4] and 
chylomicron-remnants [5,6], or by contributing to re- 
verse cholesterol transport by facilitating the delivery 
of HDL cholesterol to the liver [1,7,8]. A number of in 
vivo and in vitro studies has indicated that expression 
of HL activity is under hormonal and dietary control 
[1,9-14]. This control might be exerted at the level of 
HL binding to the endothelium [11], or by synthesis, 
intracellular degradation and secretion in the hepato- 
cytes [9,12]. 
Rat HL in heparin-containing liver peffusates, and 
secreted by isolated parenchymal cells, is a glyco- 
protein with M, 58000 on SDS-PAGE [15-17]. In liver 
homogenates, and in rat hepatoma cells or freshly 
isolated hepatocytes, a form of HL has been detected 
with a lower M r of approx. 53000 [16-18]. Pulse-label 
studies have established a precursor-product relation- 
ship, the 53 kDa-form being the high-mannose type 
intermediate of the mature, complex type protein [16- 
18]. Once secreted, the mature protein shows full cat- 
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alytic activity. How enzyme activity of iritracellular HL 
relates to the process of maturation is unknown. 
In an attempt o address this issu,z, we determined 
the specific enzyme activity of int:acellular HL and 
found it to be much lower than that of secreted HL. 
This might indicate the existence= of inactive, 9r less 
active, HL within the cells. For lirJoprotein lipas¢ (LPL), 
which is closely related to HL, also inactive forms have 
been detected within adipocy,es [19,20]. Tile inactive 
LPL molecules were hypothesized to represent he 
precursor form of active enzyme [19,20], or LPL pro- 
tein after partial intracellular degrada~,ion [20]. Re- 
cently, however, Ailhaud and co-workers [21,22] showed 
that intraccllular LPL could be activated in vitro by 
mere dilution of cell lysates into buffer. This led the 
authors to suggest that intracellular LPL molecules are 
stored in a condensed state, which masks their catalytic 
activity. These observations prompted us to study the 
possible existence of inactive, intracellular forms of HL 
into greater detail. The immunological data presented 
here strongly suggest he existence within freshly iso- 
lated rat hepatocytes of inactive HL molecules, which 
unlike LPL, cannot be activated in vitro. 
Materials and Methods 
Materials 
Castanospermine and N-methyldeox'ynojirimycin 
were purchased from Genzyme (Boston MA, U.S.A.), 
whereas cycloheximide and CHAPS were from 
Boehringer Mannheim (F.R.G.). Glycerol tri[9,10(n)- 
~H]oleate and [9,10(n)-~ H]oleic acid were obtained from 
Amersham International (U.K.), at specific radioactivi- 
ties of 1 and 2.5 Ci/mmol, respectively. Heparin 
(Thromboliquine) was a product of Organon Teknika 
(Boxtel, The Netherlands). Sepharose-heparin was pre- 
pared from CNBr-activated Sepharose 4B (Pharmacia, 
Uppsala, Sweden) according to the manufacturers in- 
structions. Ham F10 medium was obtained from Flow 
Lab (U.K.) and bovine serum was from BioTrading 
(Wilnis~ The Netherlands). Alkaline phosphatase-con- 
jugated goat anti-mouse IgG was purchased from Tago 
(Burlingame CA, U.S.A.) and p-nitrophenol phosphate 
and oleic acid were from Merck (Darmstadt, F.R.G.). 
All other chemicals were from Sigma. Polystyrene 96- 
well EIA plates (code 3590) were from Costar (Cam- 
bridge MA, U.S.A.). 
Antibodies 
An antiserum was raised in a goat against rat HL 
purified to homogeneity from liver perfusates by the 
nlethod of Jensen and Bensadoun [15]. The lgG-frac- 
tion was purified from plasma by two successive precip- 
itations each with 50% (NH4)2SO 4 and 17% NazSO 4 
followed by extensive dialysis against Dulbecco's phos- 
phate-buffered saline (PBS). Final protein concentra- 
tion was 20 mg/ml. The titer of this preparation was 
determined by immunoinhibition of HL activity from a 
liver perfusate (see below), and amounted to approx. 
3500 mU/ml. Non-specific lgG's, isolated similarly 
from the serum of a non-immunized goat, failed to 
inhibit HL activity. In a Western blot of a heparin-con- 
taining liver perfusate, a single protein with M r 58000 
corresponding to HL was recognized by the anti-HL 
IgG preparation, but not by the control IgG's (data not 
shown). 
The monoclonal antibody preparation used here was 
a mixture of five different hybridoma supernatants 
which have been described in detail previously [23]. 
The titer of this preparation amounted to approx. 20 
mU/ml. 
Hepatocyte isolation and incubation 
Hepatocytes were isolated from male Wistar rats 
(250-300 g body weight) by collagenase perfusion, and 
non-parenchymal ceils were removed by differential 
centrifugation as described previously [24]. Cell viabil- 
ity was 4etermined by Trypan blue exclusion and ranged 
from 85 to 90%. The cells were suspended at a density 
of approx. 4.10 ~' cells/ml in Ham FI0 medium contain- 
ing 50 U/ml of heparin and 20% of heat-inactivated 
rat or bovine serum [25]. Cell suspensions were incu- 
bated at 37 °C under an atmosphere of 5% CO2/95% 
0 2 in a shaking water bath. At the times indicated, 
samples of cell suspension were collected. The cells 
were separated from the medium by centrifugation 
(50 × g, 2 min, room temp.), and the cell-free medium 
was used for analysis of secreted HL. For analysis of 
intracellular lipase, the cells were washed once in PBS 
and finally resuspended at 30.106 cells/ml in PBS 
containing heparin (50 U/ml), PMSF (1 mM; from a 
200 mM stock solution in methanol), benzamidine (1 
mM), leupeptin (10/zg/ml), aprotinin (1.5/~g/ml) and 
EDTA (1 mM). This suspension was rapidly frozen to 
-80  ° C. After slow thawing on ice, the cells were 
sonified for three cycles of 5-10 s (MSE 150, ampli- 
tude 10 ~z, on ice). Thereafter, the homogenates were 
centrifuged (10 min, 10000xg, 4°C), and the super- 
natant was assayed for HL. 
Hepatic lipase activity 
HL activity is defined here as the lipase activity that 
was sensitive to immunoinhibition with polyclonal anti- 
HL antibodies. Lipase activities were determined by a 
triacylglycerol hydrolase assay at pH 8.5 in 0.6 M NaCI 
using a gum acacia stabilized glycerol [3H]trioleate 
emulsion as substrate [25]. Assays were performed for 
30 rain at 30°C and a substrate concentration of 3.2 
mM, unless otherwise stated. At the end of the assay, 
the free fatty acids were extracted [25]. In a standard 
assay, never more than 120 nmol of fatty acids (10% of 
total substrate) were released. Enzyme activities were 
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expressed as mU (nmol of free fatty acids released per 
min). 
In immunoinhibition tests, 40 p,l of cell-free media 
and 41) ul of properly diluted cell homogenates were 
mixed with 10/~! of the polyclonal anti-HL preparation 
described above. After incubation for I h at 0 ° C, 75 ~1 
of substrate was added and residual Iipase activity was 
determined. In the experiments reported here, more 
than 70% and 95% of total lipase activity in cell 
homogenates and cell-free media, respectively, was in- 
hibited by preincubation with anti-HL. 
Control experiments howed quantitatively similar 
results when cell homogenates were assayed in the 
absence or presence of 20% serum (data not shown); 
dilutions of cell homogenates were therefore routinely 
made in PBS without serum. The triacyiglycerol con- 
tent of cell homogenates amounted to i.2 + 0.1 mM 
(mean 4- S.D., n = 3), which would result in a dilution 
of radiolabelled substrate of only 10% with the highest 
amount of homogenate used per assay. The efficiency 
of free fatty acid extraction, which was quantified by 
using a gum acacia stabilized emulsion of unlabelled 
trioleate containing [3H]oieic acid (specific radioactiv- 
ity 1.o mCi/mmol; final concentration i the assay 125 
/~M), amounted to 60.3 + 1.6% (mean + S.D., n = 20). 
This value was not significantly different between as- 
says on cell-free media and cell homogenates (data not 
shown). En~me activity data were not corrected for 
this extraction efficiency. 
In experiments designed to determine the oH de- 
pendency of lipase activity, the buffers (0.1 M) used in 
the substrate mixture were sodium acetate (pH 4.0 and 
oH 5,0), sodium phosphate (pH 5.8, oH 6.6 and oH 
7.3), Tris-HC! (pH 8.0 and oH 8.9), and glycine-NaOH 
(pH 9.6 and oH 10.3). 
ELISA for rat hepatic lipase 
A solid-phase ELISA was developed for rat HL 
using the goat polyclonal and the mixture of monoclon- 
aIs described above as the primary and secondary anti- 
body, respectively [26]. In short, microtiter plate wells 
were coated with 20 #g of the goat anti-HL IgG. After 
blocking with 1% gelatin in PBS, the wells were incu- 
bated successively with: (i)sample; (ii) the monocional 
antibodies at a 1:5 dilution, and (iii) alkaline phos- 
phatase-conjugated goat anti-mouse IgG af a 1:500 
dilution. To reduce non-specific binding, incubations 
were performed in the presence of l M NaCl, 0.1% 
Tween-20 and 0.5% BSA in PBS. Finally, alkaline 
phosphatase was assayed using p-nitrophenol phos- 
phate, and absorbances were read at 405 nm in a 
Titertek EIA analyzer. For each plate used in the 
ELISA, serial dilutions of purified HL were included 
as standards. Rat HL was purified from post-heparin 
liver perfusates exactly as described by Jensen and 
Bensadoun [15] but with omission of the last gel-filtra- 
tion step, The final preparation contained 338 /.tg/ml 
of protein, and was stored at -80  °C until use. The 
standard curves showed the ELISA to be sensitive 
from It) to 1000 ng/ml. 
A ffim~ chromatography 
To enable partial purification of intracellular and 
extraccllular HL by affinity chromatography on 
Sepharose-heparin, the heparin concentration used in 
the secretion experiments and in the preparation of 
cell homogenates was reduced to 10 U/ml.  Samples 
(2.5 ml) of secretion media and corresponding ceil 
homogenates were applied to 1 ml of Sepharose- 
heparin poured in a Pasteur pipette. The column was 
washed with 2.5 ml of 0.2 M NaCI in a 10 mM sodium 
phosphate buffer (pH 7.2) containing 20% glycerol (by 
vol.). Bound enzyme was eluted from the column with 
1 ml portions of the same buffer containing succes- 
sively, 0.4, 0.6, 0.8, 1.0, 1.2 and 2.0 M NaCI. The entire 
procedure was performed at 4 ° C, Total recovery of 
lipase activity was 82 + 18% and 90 + i3% (mean + 
S.D., , =4)  for the secretion media and cell ho- 
mogenates, respectively. 
Other methods 
For the determination of kinetic parameters, the 
glycerol tri[~H]oleate emulsion was serially diluted with 
5% (w/v) gum acacia in 8 mM NaHCO 3 (pH 9), to 
yield final concentrations of 9.6 to 0.3 mM in the assay 
mixture. Assays were performed as described above. 
The kinetic parameter Vm;,x (maximal velocity) was 
estimated from the linear part of Hanes plots, and the 
parameters K~, op (apparent substrate half-saturation 
constant) and h (Hill coefficient)were subsequently 
estimated from Hill plots using the method of least 
squares [27]. 
Protein was determined by the method of Bradford 
[28] using BSA as standard. The triacylglyceroi content 
of cell homogenates was determined after Folch ex- 
traction [29] using a Boehringer test kit. Statistical 
significances were determined by Student's t-test. 
Results 
Assay of intracelhdar IlL actirity 
Fig. IA shows the relationship between the amount 
of cell homogenate used in the assay and the lipase 
activity measured. The release of free fatty acids from 
the -~H-iabelled trioleate substrate increased linearly 
with homogenate volumes up to approx. 5/a,t per assay, 
where about 1 nmol of fatty acids was released. At 
higher volumes, product formation levelled off, and 
above 20 ~1 per assay no further release of fatty acids 
was ebse~ed (Fig, IA). With the cell-free media, how- 
ever, free fatty acids increased linearly with sample 
volumes at least up to 15 nmol of product (Fig. IA), 
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Fig. 1. Optimalization of the lipase assay on cell homogenates. Freshly isolated rat hepatocytes were washed with several volumes of cold PBS 
containing 50 U/ml of heparin to remove any extracellularly bound HL [401. Homogenates were prepared by freeze-thawing and sonification, as 
described in the Methods section. A cell-free medium containing secreted HL was prepared after a 2 h-incubation of freshly isolated rat 
hepatocytes with 20% serum and 50 U/ml of heparin. In A, different amounts of the homogenate ( ) and ceil-free medium (o) were tested for 
HL activity in the standard 30-min assay. In B, the relation of HL activity with assay time was measured using either 5/~i (e) or 25 p.! (• )  of cell 
homogenate; for the cell-free medium fatty acid release was linear with assay time throughout incubation, even when tested at 50/~i per assay 
(data not shown). Insert: the effect of various amounts of homogenate was determined on the initial rate of triacylglyeerol hydrolysis, measured 
as the number of fatty acids released after 2 man of incubation. Data are expressed as means:t: S.D. (n = 4). 
ruling out the possibility of limiting substrate at the 
higher homogenate volumes. When the data on fatty 
acid release were expressed as mU/ml of homogenate, 
a 5-fold increase in lipase activity became apparent 
upon an 8-fold dilution into heparin-containing buffer, 
No additional effect was observed upon further dilu- 
tion. 
A number of observations indicate that the mecha- 
nism of in vitro activation differs from that described 
for LPL [20,21]. The dilution effect on HL activity 
appears independent of detergents as similar dose-re- 
sponse curves were obtained when diluted in 4 mM 
CHAPS or 0.02% Triton X-100 (data not shown). As 
shown in Fig. 1B, fatty acids were released at a con- 
stant rate during the 30-man assay with 5 p,l cell ho- 
mogenate. At 25 gl, however, product formation 
showed biphasic kinetics with a rapid burst during the 
initial few minutes, and a slow second phase thereafter. 
The rate of product formation during this second phase 
was slightly higher than that observed with 5 ~1 ho- 
mogcnate, The initial burst in fatty acid production 
increased linearly with sample volumes (Fig. 1B, insert). 
Hence, the dilution effect was not apparent when 
intracellular HL activity was measured as the initial 
rate of product formation. Recombination of various 
amounts of cell homogenate with a constant amount of 
a liver perfusate containing HL activity indicated the 
presence of an inhibitory compound in the cell ho- 
mogenate (Fig. 2). Above 10 ~1 of cell homogenate, 
HL activity in the perfusate and the homogenate were 
no longer additive, and at 25 ~i of homogenate, only 
60% of total activity was detected. Inhibition was not 
due to PMSF [30] or any of the other proteinase 
inhabiters used, as a similar inhibition was observed 
when prepared in their absence. Moreover, ultrafiltra- 
tion through a membrane with 30000 molecular weight 
cutoff failed to remove the inhibitory activity (data not 
shown). The inhibitor was lost after heating the ho- 
mogenate for 10 man at 56 ° C, or after extraction with 
acetone:diethyl ether (1:1, v/v). No further attempts 
were made to identify this inhibitory compound. 
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Fig. 2. Effect of homogenate on the HL activity in a liver perfusate. 
Various amounts of a cell homogenate were tested for HL activity, 
either alone (• ), or immediately after mixing with a constant amount 
of HL activity from a liver perfusale (3.54-0.3 mU/ml, e). HL 
activity measured in the combined samples was compared with the 
sum of the activities measured separately (o). At homogenat¢ vol- 
umes of 15 #[ and above, the values measured were significantly 
lower than those calculated (P < 0.05; n = 4). The activity in the liver 
perfusate was not affected by the addition of the homogenization 
buffer (after freeze-thawing) alone ( - - - - - - ) .  
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These observations indicate that the dilution effect 
on HL activity is due to the presence of an inhibitor in 
the cell homogenate. Apparently, this inhibitory com- 
pound is diluted to below a critical concentration when 
tested at 5 p,I homogcnate and less. In all subsequent 
assays of intracellular HL activity, 5/1I of homogenate 
were tested. Using this assay, 13 + 3 mU/ml  (mean + 
S.D., n = 8) of HL activity were detected in liver cell 
homogenates, which corresponds to approx. 0.4 mU 
per 10 ~' cells. 
Comparison between intracelhdar and ertracelhdar HL 
lmmunotitrat ion of intracellular HL and HL se- 
creted in vitro by freshly isolated hepatocytes showed 
inhibition of intracellular HL activity with polyclonal 
anti -HL at much higher amounts of antibody (Fig. 3). 
In three independent experiments, 4 to 5-times more 
anti-HL antibody was required to inhibit a similar 
amount of enzyme activity present in a cell ho- 
mogenate than that or" extracellular HL. When the 
amount of HL protein was measured by an ELISA for 
rat HL, the specific enzyme activity of secreted, extra- 
cellular HL amounted to 9 + 5 rnU/p,g, whereas that 
of intracellular HL was 1.8 + 0.9 mU/p .g  (means + 
S.D., n = 6; P < 0.01). Hence, the specific enzyme ac- 
tivity of intracellular HL was 5-fold less than that of 
secreted HL. 
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Fig. 3. Immunotitration of intracellular and secreted HL. A cell 
homogenate and cell-free medium were prepared from a control 
suspension after a 2 h-incubation with 50 U/ml of heparin. After 
pre-incubation for 1 h at O°C with different amounts of polyclonal 
anti-HL, substrate was added to a final concentration f 9.6 raM, and 
residual ipase activity was assayed. The cell-free medium (el was 
diluted with Ham FI0 containing 20% serum and 50 U/ml heparin 
to obtain an activity comparable to the cell homogenate (•). Results 
are expressed as the percentage of HL activity measured after 
incubation with non-immune igG, which amounted to 1.3 and 1.6 
mU/ml for the cell-free medium and cell homogenate, respectively. 
Data are representative of three similar experiments, insert: Im- 
munotitration of intracellular (• )  and secreted (el HL activity after 
partial purification on Sepharose-heparin. Respective HL activities 
were 2.0 and 2.3 mU/ml. Data are representative of four similar 
experiments. 
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Fig..1 pl-t dependency of intracel!ular lipase and secreted HE 
tlep,ttocytes ~rc  incubated for 2 h iu control medium containing 
2lit; - serum and 50 U/ml heparin and cell homogenates (o. e) and 
cell-free media (•)  were prepared. After pre-incubation for 1 h at 
0 ° C with either non-immune lgG (e, II) or pol~'clonal anti-HL (c'). 
triacylglycerol hydrulase activity wa,~ determined at different assay 
pHs. Data are expressed as means_+ S.D. (n --- 4). 
Characterization of bztracelhdar HL acticity 
The lipase activity of HL secreted in vitro showed a 
sharp optimum at pH 8.9-9.5 (Fig. 4), similar to that 
for HL in a liver perfusate (data not shown), in con- 
trast, the lipase activity of control cells showed a broad 
pH optimum at pH 6.5-9. After pre-incubation with 
polyclonal anti-HL, lipase activities measured at pH 8 
and above were abolished, whereas activities below pH 
7 remained unaffected. In homogenates prepared from 
cycloheximide-treated cells (see below), lipase activity 
showed a pH dependenc3' similar to the latter curve, 
i.e., that obtained with the control homogenates after 
immunoinhibit ion with anti-HL (data not shown). These 
findings confirm previous reports on the presence of 
multiple lipase activities within rat liver [31], and 
demonstrate a similar pH dependency for extracellular 
and intraceltular HL activity. Moreover, these data 
indicate that, of  all intracellular lipases, cyclohex- 
imide-treatment selectively affects HL activity under 
the conditions used here. 
The HL activity in cell-free media and cell ho- 
mogenates both showed slightly sigmoidal kinetics with 
respect to the glycerol-trioleate substrate (not shown). 
Estimated Hill coefficients were in the range of 1.2 to 
1.7, and were not significantly different from each 
other (Table !). K~ pp values were significantly higher 
for HL in homogenates than in ceil-free media. Addi- 
tion of a 5 #l-sample of homogenate to 45 /zl of 
cxtracellular HL induced a similar upward shift in 
K~'P" of the latter without affecting l,m, x or 11 (not m 
shown). This observation suggests that the homogenate 
contains a compound that reduces the affinity of HL 
for its substrate. 
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Partial purification of HL on Sepharose-heparin 
Of the HL activity present in a cell homogenate, 
only 25_+ 10% (means _+ S.D., n = 4) was bound to 
Sepharose-heparin, whereas virtually all HL activity in 
secretion media was bound. In both cases, bound activ- 
ity eluted at 0.6 M NaCI. After isolation, the dilution 
effect on intracellular HL was no longer observed. 
fmmunotitration with polyclonal anti-HL showed inhi- 
bition of intracellular HL activity at 3-4-fold higher 
amounts of antibody than for secreted HL (Fig. 3, 
insert), indicating that the difference in specific en- 
zyme activity was maintained throughout isolation. Af- 
ter isolation, the g';'r'r' of intracellular HL was markedly 
~ m  
reduced to a value that was no longer different from 
that of secreted HL (Table I). The estimated Hill 
coefficient was not affected by the isolation procedure. 
These data indicate that, except for the 3-4-fold differ- 
ence in specific enzyme activity, intracellular and se- 
creted HL have similar kinetic properties. 
Effect of cycloheximide and castanospermine 
Incubation of hepatocytes with cycloheximide com- 
pletely blocks protein de novo synthesis but Ieaves the 
secretion of intracellular HL from a pre-existing pool 
intact [26]. After 2 h of incubation, intracellular HL 
activity was completely depleted (Fig. 5), Simultane- 
ously, the amount of HL pro'ein was markedly re- 
duced. Castanospermine, which interferes with HL 
maturation by inhibiting N-linked oligosaccbaride pro- 
cessing at the level of trimming glucosidases in the 
rough endoplasmic reticulum, also leaves secretion of 
HL already processed beyond this point unaffect~zd 
[26]. After 2 h of incubation with this inhibitor, HL 
activity was no longer detectable intracellularly. The 
amount of HL protein was also reduced with respect o 
the untreated controls, but substantial amounts of HL 
protein remained detectable. In five indeper~dent ex- 
periments, the amount of HL protein in castanosper- 
mine-treated cells was significantly higher than that in 
TABLE I 
Kinetic parameters ofintracelhdar ttd secreted HL 
The kinetic parameters K~, pp and h (Hill coefficient) were deler- 
mined as described iv. the Methods ection for HL triacyLglycerol 
hydroDse activity, either directly in cell homogenates and cell-free 
media, or after isolation on Sepharose-heparin. Data are means!  
S.D. for three to five independent experiment.', 
Enzyme preparation K'mP (mM) h ==  
Secreted HL 
ceil-free medium 1.4 +_ 0.2 
after ist)latit)n 0.8 + 0. ! 
lntracetlular HL 
celt homogenate 4.6_+ 1.0 
after isolation 0.9 _ fl.3 
15 _+ 0.2 
tA_+O.I 
1,3+_0.2 
1.2_0.1 
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Fig. 5. Effect of castanospermine and cyeloheximide on intracellular 
HL. Hepatocytes were incubated for 2 h in the absence of any 
inhibitor (C). or in the presence of100 ttg/ml castanospermine (Cs) 
or 10 p.g/ml of cycloheximide (CH). At the end of the incubation, 
cell homogenates were prepared and analyzed for HL  activity (open 
bars) and HL protein by EL~SA (closed bars). Data are means 4-S.D. 
of five independent experimenls. 
cycloheximide-treated cells (P < 0.05, by paired Stu- 
dent's t-test). Similar results were obtained with N- 
methyideoxynojirimycin, a  alternate inhibitor 0f trim- 
ming glucosidases (data not shown). These observa- 
tions suggest he presence of inactive HL within the 
cells. 
Secretion-coupled increase in specific HL activity 
Cells were first washed ~ith several volumes of cold 
PBS containing 50 U/ml of heparin to remove any 
extracellularly bound HL, and then incubated for 2 h 
with cycloheximide. No further HL secretion occurred 
upon prolonged incubation [26]. HL protein and activ- 
ity were measured in the cell homogenates prepared 
just before addition of ¢ycloheximide, and in the cell- 
free media prepared at the end of the 2 h-incubation. 
The ELISA revealed that the amount of HL protein 
that disappeared from the cells during the incubation 
was completely recovered in the extracellular medium. 
In five independent experiments, the secretion poten- 
tial, taken as the ratio of total secreted amount o the 
lost cellular amount, was 1.3 +_ 0.3 (mean +__ S.D., n = 5). 
In contrast, more HL activity was secreted than was 
initially present within the cells; for HL activity, the 
secretion potential amounted to 5.2 + 2. I (mean + S.D., 
n = 5). Apparently, the specific enzyme activity of HL 
increased approx. 4-fold upon secretion. 
Recoeery from castanospermbw inhibition 
We then tested whether the inactive HL detected in 
~:astanospermine-treated cells was still available for 
further maturation and secretion. After 2 h of incuba- 
tion with castanospermine, the inhibitor was removed 
by washing the cells in PBS followed by incubation of 
the cells without castanospermine. HL activity became 
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Fig. 6. Recovery from castanospermine inhibition. Hepatocytcs were 
pre-incubaled for 2 h in the presence of 1110 #g/ml castlmosper- 
mine. After washing the cells free of inhibitor, incubation was 
continued either in the absence to) or presence of 10/zg/ml cyclo- 
heximide (•). At the times indicated, samples were withdr~twn for 
analys is  o f  secreted  I l L  activity. Data  arc  means+S.D,  or" four  
independent  exper iments .  
detectable in the extracellular medium after a lag-time 
of approx. 30 min (Fig. 6). Thereafter, secretion pro- 
ceeded at a constant rate throughout incubation. When 
cycloheximide was present during recovery from cas- 
tanospermine inhibition, considerable amounts of HL 
activity were secreted into the extracellular medium. 
Again, secretion was delayed by approx. 30 min, Now, 
secretion proceeded at a lower rate than in the absence 
of cycloheximide, and completely stopped after 90 rain. 
After 2 h of incubation, the specific enzyme activity of 
HL in the extracellular medium was 7.7 + 2.3 and 
8.9 + 2.9 mU//zg in the presence and absence of cyclo- 
heximide, respectively (means + S.D., n = 4; P > 0.1), 
These data suggest that at least part of the inactive HL 
protei.: observed in castanospermine-treated cells was 
mobilized for further maturation and secretion, during 
which the catalytic activity of HL protein became de- 
tectable. 
Discussion 
This study demonstrates, by immunotitration with 
polyelonal anti-HL (Fig. 3), and by triacylglycerol hy- 
drolase assays combined with ELISA using a mixture 
of monoclonal anti-HL's, that the specific enzyme ac- 
tivity of intracellular HL is 3- to 5-fold lower than that 
of extracellular HL. Upon secretion into the extracellu- 
lar medium, the specific catalytic activity of HL in- 
creased approx. 5-fold. This indicates that of all intra- 
cellular HL protein, only 20-25% is fully active. Alter- 
natively, all intracellular HL protein might be equally 
active but at a specific activity of only 20-25% of that 
of secreted HL. The latter possibility seems unlikely, as 
HL protein with virtually no catalytic activity could be 
demonstrated in cycloheximide- and castanospermine- 
treated hepatocytes (Fig. 5). Inactive forms of HL 
might either be the product of intracellular degrada- 
tion, or represent an inactive precursor of the function- 
ally mature protein. In the presence of heparin and 
cycloheximide the cells were depleted of HL activity, 
but part of immunoreactive protein remained within 
the cells (Fig. 5). This residual protein may represent 
intracellularly inactivated HL. The finding that cas- 
tanospermine-treated c lls, containing only inactive HL 
(Fig. 5), were able to secret,: fully active en~me even 
in the absence of protein de novo synthesis (Fig. 6), 
strongly argues in favor of a precursor-product rela- 
tionship. Hence, the occurrence of intracellular activa- 
tion of HL in rat hepatocytes i  clearly 'indicated. 
For LPL. which belongs to the same gene family as 
HL (Ref. 32, and references therein), inactive intra- 
cellular fi~rms have been demonstrated in 3T3-L1 
adipocytes [20], whereas a secretion-linked increase in 
the specific catalytic activity was shown to occur in 
some mouse adipocytes and in rat stromal-vas':ular 
cells [19.21.22.33]. In Ob17 adipocytes, intracellular 
activation of LPL occurred after LPL protein exits 
from the endoplasmic reticulum and before it reaches 
the tr, ns-Golgi cisternae [19]. Activation of LPL 
molecules in 3T3-F422A cells appears closely associ- 
ated with the formation of LPL dimers [34], which 
occurs within the Golgi apparatus. In this oligomeriza- 
tion process, N-linked oligosaccharide processing ap- 
pears to play a permissive role as improperly glyco- 
sylated LPL fails to form dimers and accumulates 
within the endoplasmic reticulum in an inactive form 
[19.34-36]. Transport of LPL protein to the Golgi 
enables oligosaccharide processing to the mature form 
which then associates to catalytically active dimers [34]. 
At which stage during maturation the catalytic activ- 
ity of HL becomes detectable remains unknown, but it 
is attractive to suppose a model similar to that for the 
activation of LPL. First, native HL is also thought o be 
an oligomeric protein [15,37]. Secondly, interference 
with N-linked oligosaccharide processing using cas- 
tanospermine or methyldeo~nojirimycin i duces a 
marked decrease in the specific catalytic activity of 
intraceilular HL (Fig. 5). Both agents are inhibitors of 
the trimming glucosidases present in the rough endo- 
plasmic reticulum [38], thus preventing the removal of 
the terminal glucose residues from core-glycosylated 
HL. Removal of these sugar residues appears essential 
to the efficient transport o the Golgi for some secre- 
tory glycoproteins [39], including HL [26]. Thirdly, the 
interpretation that of all intracellular HL protein ap- 
prox. 75% is inactive, fits with a model that the activa- 
tion process occurs rather late during maturation. In 
this respect it is noteworthy that HL is not stored in 
secretory vesicles but rapidly secreted from hepato- 
cytes [16,17]. For Fu5AH rat hepatoma cells treated 
with heparin, the total transit time of HL was esti- 
56 
mated at 31 min, whereas the half-residence time in 
the endoplasmic reticulum-cis Golgi region was esti- 
mated at 25 min [17,40], indicating extremely rapid 
secretion of HL from the Golgi. For rat hepatocytes, 
the observed 30 mi,~ lag in the recovery of HL secre- 
tion from castanospcrmine inhibition (Fig. 6), as well 
as the lag observed between inhibition of protein de 
novo synthesis and inhibition of HL secretion [26] are 
in accordance with such short intracellular transit times. 
The mechanism of intraceIlular HL activation re- 
mains unknown. Although N-linked oligosaccharide 
processing appears important, as illustrated by the 
effect of castanospermine and methyldeoxynojirimycin, 
the activity state of the protein is probably only indi- 
rectly determined by its glyean structure (see above). In 
a recent report [35], Doolittle and co-workers claim 
that unglycosylated HL obtained after site-directed 
mutagenesis was secreted by transfected cells and was 
catalytically active, but further details were not given. 
Probably, other post-translational modifications of the 
HL protein are involved. Alternatively, HL protein 
may be potentially active, but its activity is masked 
throughout most of intracellular transportation. In re- 
cent studies using adipocytes and muscle cells, Ailhaud 
and co-workers [21,22] showed that active LPL 
molecules are stored intracellularly in a condensed 
state which masks catalytic activity. Unmasking was 
achieved in vitro by mere dilution of the cell lysate. We 
observed a similar dilution effect for HL in ho- 
mogenates prepared from rat liver cells (Fig. 1). How- 
e~,er, even when assayed at the proper dilutions, or 
after isolation on Sepharose-heparin, the specific cat- 
alytic activity of intracellular HL remained less than 
that of secreted HL. Moreover, recombination experi- 
ments with a liver perfusate indicated the presence in 
homogenates of inhibitory compounds (Fig. 2) that 
reduce the affinity of HL for its triacylglycerol sub- 
strate. Apparently, dilution of the cell homogenates 
was required to reduce the inhibitory compound in the 
assay. The nature oi this inhibitor remains presently 
unknown. 
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